Bayban’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$147K Buy
127
+6
+5% +$7.08K 0.11% 133
2026
Q2
$145K Sell
121
-37
-23% -$37.8K 0.11% 132
2026
Q1
$145K Hold
158
– – 0.13% 130
2025
Q4
$170K Buy
+158
New +$151K 0.15% 108

Other funds holding LLY

Bayban's LLY Position: Q3 2026 in Review

Bayban increased its Eli Lilly (LLY) stake by 5% in Q3 2026, buying an estimated $7.08K and bringing the position to 127 shares worth $147K. The position accounts for 0.11% of the portfolio, ranked #133.

Bayban first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $170K in Q4 2025. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Bayban held 127 shares of Eli Lilly worth $147K as of Q3 2026.
  • Bayban bought 6 Eli Lilly shares in Q3 2026, an estimated $7.08K.
  • Eli Lilly made up 0.11% of Bayban's portfolio in Q3 2026, its #133 holding.
  • Bayban first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Bayban's Eli Lilly position peaked at $170K in Q4 2025.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.